Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency

Adriana Ordóñez; Carmen de Cos; Antonia Miñano; Javier Rodríguez; David Hernández-Espinosa; Juan A. Muñoz; Rocio González-Conejero; Vicente Vicente; Javier Corral

doi:10.1160/TH06-08-0440

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2007; 97(01): 153-155
DOI: 10.1160/TH06-08-0440

Case Report

Schattauer GmbH

Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency

Adriana Ordóñez

¹Centro Regional de Hemodonación, University of Murcia, and

,

Carmen de Cos

²Haematology Service, Hospital Puerta del Mar, Cádiz, Spain

,

Antonia Miñano

¹Centro Regional de Hemodonación, University of Murcia, and

,

Javier Rodríguez

²Haematology Service, Hospital Puerta del Mar, Cádiz, Spain

,

David Hernández-Espinosa

¹Centro Regional de Hemodonación, University of Murcia, and

,

Juan A. Muñoz

²Haematology Service, Hospital Puerta del Mar, Cádiz, Spain

,

Rocio González-Conejero

¹Centro Regional de Hemodonación, University of Murcia, and

,

Vicente Vicente

¹Centro Regional de Hemodonación, University of Murcia, and

,

Javier Corral

¹Centro Regional de Hemodonación, University of Murcia, and

References
1 Heit JA, Silverstein MD, Mohr DN. et al Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-53.
2 Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005; 3: 1611-7.
3 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
4 Corral J, González-Conejero R, Soria JM. et al A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis. Blood 2006; 108: 177-83.
5 Corral J, Huntington JA, Gonzalez-Conejero R. et al Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis. J Thromb Haemost 2004; 2: 931-9.
6 Bayston T, Lane D.. Imperial College of London. Antithrombin mutation database. http://wwwfom.sk.med.ic.ac.uk/medicine/about/divisions/is/haemo/coag/antithrombin/LastrevisionAugust2006.
7 OMIM http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107300
8 HGMD http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SERPINC1
9 The Serpin Database. Structural medicine http://www.tructmed.cimr.cam.ac.uk/Serpins/serp_regions/table2.html Last revision August 2006
10 Wu YI, Sheffield WP, Blajchman MA. Defining the heparin-binding domain of antithrombin. Blood Coagul Fibrinolysis 1994; 5: 83-95.
11 Corral J, Rivera J, Martinez C. et al Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: New application for a classical method. J Lab Clin Med 2003; 142: 298-305.
12 Perry DJ. Ectopic transcript analysis in human antithrombin deficiency. Blood Coagul Fibrinolysis 1995; 6: 531-6.
13 Van Boven HH, Reitsma PH, Rosendaal FR. et al Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-21.
14 Vossen CY, Walker ID, Svensson P. et al Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol 2005; 25: 1992-7.
15 Beauchamp NJ, Pike RN, Daly M. et al Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. Blood 1998; 92: 2696-706.
16 Brenner B. Thrombophilia and fetal loss. Semin Thromb Hemost 2003; 29: 165-70.
17 Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med 2006; 24: 54-66.